InhaleRx secures A$38.5m deal to accelerate pain and mental health breakthroughs
Melbourne-based healthcare innovator InhaleRx Limited (ASX: IRX) has secured a substantial funding deal worth up to AUD 38.5 million, aiming to revolutionize the treatment of pain management and mental health disorders. The deal, inked with Clendon Biotech Capital, is set to fund the clinical development of two of InhaleRx’s breakthrough drug-device products, IRX-211 and IRX-616a, […]